Katrina Perehudoff
Katrina Perehudoff - Can law help make the market for medicines, vaccines and other health products more transparent? Recently, Katrina Perehudoff led the Medicines Law & Policy team to publish a report, commissioned by WHO, on this issue. She answers four legal questions. What exactly is going on with medicines prices? . 'The high cost of research and development (R&D, red.) for new medicines and health products is often used to justify their high prices. Although R&D can be costly, there is little objective and transparent information about the actual costs of R&D and the prices, meaning, prices net of discounts and rebates, that governments pay to purchase health products. This lack of transparency hampers governments from making fully informed decisions when negotiating the prices of health products for their populations. The result can be detrimental for public health: governments may spend too much on a medicine, leaving less funding for others.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
